-
生物通官微
陪你抓住生命科技
跳动的脉搏
《Nature》专题:被忽视的疾病
【字体: 大 中 小 】 时间:2007年09月27日 来源:生物通
编辑推荐:
热带疾病给10多亿人类带来了无尽的痛苦,但是至今为止有效的治疗方法并不多,而且虽然进行了许多科学研究,但是许多具有治疗潜力的科学创新并不能从实验室里走出来。 《Nature》杂志最新副刊以“Neglected diseases”为题,提示大家关注这一领域,也审视了促进有效医药发展,以及将这些方法传递给最需要的人的处理办法。
生物通报道:热带疾病给10多亿人类带来了无尽的痛苦,但是至今为止有效的治疗方法并不多,而且虽然进行了许多科学研究,但是许多具有治疗潜力的科学创新并不能从实验室里走出来。
《Nature》杂志最新副刊以“Neglected diseases”为题,提示大家关注这一领域,也审视了促进有效医药发展,以及将这些方法传递给最需要的人的处理办法。
David O'Connell
doi:10.1038/449157a
The culture of academia needs to change if scientists are to bridge the gap between research and the development of drugs and vaccines for neglected diseases in the developing world, says Declan Butler.
Declan Butler
doi:10.1038/449158a
What is holding back biotechnology in the developing world? Peter A. Singer and his colleagues listen to those on the ground.
Peter A. Singer, Kathryn Berndtson, C. Shawn Tracy, Emma R. M. Cohen, Hassan Masum, James V. Lavery & Abdallah S. Daar
doi:10.1038/449160a
Full Text | PDF (818K) | Supplementary information
Governments must help accelerate the development of drugs needed to treat infectious diseases in the developing world, say Bénédicte Callan and Iain Gillespie.
Bénédicte Callan & Iain Gillespie
doi:10.1038/449164a
One billion people worldwide suffer from tropical diseases. Andrew L. Hopkins, Michael J. Witty and Solomon Nwaka explain how drug-discovery networks might be scaled up to address the lack of treatments cost-effectively.
Andrew L. Hopkins, Michael J. Witty & Solomon Nwaka
doi:10.1038/449166a
Improvements in basic infrastructure are the key to saving millions of lives each year, say Julian Lob-Levyt and his colleagues.
Rebecca Affolder, Ivone Rizzo, Craig Burgess, Abdallah Bchir & Julian Lob-Levyt
doi:10.1038/449170a
Protecting intellectual property saves lives in the developing world, argues Paul Herrling.
Paul Herrling
doi:10.1038/449174a
Differential pricing could make global medicines affordable in developing countries. But drugs for diseases that have no market in the developed world will require additional subsidies, says Patricia M. Danzon.
Patricia M. Danzon
doi:10.1038/449176a
Brazil urgently needs to improve infrastructure for generating pharmaceuticals to alleviate the plight of its poor and marginalized populations, say Carlos M. Morel et al.
Carlos M. Morel, José R. Carvalheiro, Carmen N. P. Romero, Eduardo A. Costa & Paulo M. Buss
doi:10.1038/449180a